The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Pregabalin (Gabafit (75 mg)) is an anticonvulsant ...

New Delhi, May 6 (PTI) Pharma major Lupin Ltd on Friday said it has received approval from the US health regulator to market its generic version of Pregabalin capsules used for the treatment of pain ...

Aurobindo has obtained the Food and Drug Administration's blessing for pregabalin capsules in dosage strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and 300 mg. Aurobindo's pregabalin ...

Pregabalin is a generic prescription drug used to treat neuropathic pain and fibromyalgia in adults. It is also used to treat partial-onset seizures in adults and certain children. The price you pay ...

Marksans Pharma Limited has received final approval from US Food & Drugs Administration for its Abbreviated New Drug Application (ANDA) for Pregabalin Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, ...

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Pregabalin Capsules a therapeutic ...

Pregabalin is a prescription drug. It comes in three forms: a capsule, a solution, and an extended-release tablet. All forms are taken by mouth. Pregabalin oral capsule is available as the brand-name ...

What to do: Check your medication bottle or package. If your prescription is for 50 mg capsules and the bottle contains any 150 mg capsules, or if you are unsure, return it to your pharmacy ...

Drug-maker Lupin today said it has received tentative approval from the US health regulator to market Pregabalin capsules, used in the treatment of chronic pain as a result from an injury to the ...

The United States Food and Drug Administration (USFDA) has given Zydus Lifesciences Limited final approval to market Silodosin Capsules, 4 mg, and 8 mg. The company also received final approval to ...

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma In the current study, we investigated the efficacy and safety of ...